Publicacions en què col·labora amb NURIA CABEDO ESCRIG (9)

2019

  1. Colaboración docente de estudiantes universitarios de Farmacia en la Enseñanza Secundaria: las dependencias a fármacos naturales

    Investigación e innovación en la Enseñanza Superior: Nuevos contextos, nuevas ideas (Octaedro), pp. 562-572

2013

  1. 2,3,9- and 2,3,11-Trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands

    European Journal of Medicinal Chemistry, Vol. 68, pp. 150-166

  2. 3,4-Dihydroxy- and 3,4-methylenedioxy- phenanthrene-type alkaloids with high selectivity for D2 dopamine receptor

    Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 17, pp. 4824-4827

2012

  1. Tetrahydroisoquinolines acting as dopaminergic ligands. A molecular modeling study using MD simulations and QM calculations

    Journal of Molecular Modeling, Vol. 18, Núm. 2, pp. 419-431

2009

  1. Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives

    European Journal of Medicinal Chemistry, Vol. 44, Núm. 11, pp. 4616-4621

  2. Terretonins E and F, inhibitors of the mitochondrial respiratory chain from the marine-derived fungus Aspergillus insuetus

    Journal of Natural Products, Vol. 72, Núm. 7, pp. 1348-1351

  3. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice

    Bioorganic and Medicinal Chemistry, Vol. 17, Núm. 14, pp. 4968-4980

2007

  1. Isolation and structural elucidation of eight new related analogues of the mycotoxin (-)-botryodiplodin from Penicillium coalescens

    Journal of Agricultural and Food Chemistry, Vol. 55, Núm. 17, pp. 6977-6983

2000

  1. Mechanism of vascular relaxation by thaligrisine functional and binding assays

    Life Sciences, Vol. 67, Núm. 13, pp. 1535-1548